PL398659A1 - Nowe pochodne (Z)-1,2-difenyloetenu - Google Patents

Nowe pochodne (Z)-1,2-difenyloetenu

Info

Publication number
PL398659A1
PL398659A1 PL398659A PL39865912A PL398659A1 PL 398659 A1 PL398659 A1 PL 398659A1 PL 398659 A PL398659 A PL 398659A PL 39865912 A PL39865912 A PL 39865912A PL 398659 A1 PL398659 A1 PL 398659A1
Authority
PL
Poland
Prior art keywords
derivatives
diphenyl
diphenylethan
new derivatives
new
Prior art date
Application number
PL398659A
Other languages
English (en)
Other versions
PL220039B1 (pl
Inventor
Tomasz Stefanski
Jakub Różański
Original Assignee
Uniwersytet Medyczny Im. Karola Marcinkowskiego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny Im. Karola Marcinkowskiego filed Critical Uniwersytet Medyczny Im. Karola Marcinkowskiego
Priority to PL398659A priority Critical patent/PL220039B1/pl
Priority to PCT/PL2013/000042 priority patent/WO2013147629A1/en
Priority to US14/389,281 priority patent/US10065935B2/en
Priority to EP13723574.3A priority patent/EP2885280A1/en
Publication of PL398659A1 publication Critical patent/PL398659A1/pl
Publication of PL220039B1 publication Critical patent/PL220039B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/04—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Przedmiotem wynalazku sa nowe zwiazki chemiczne zawierajace w swojej strukturze uklad (Z)-1,2-difenyloetenu, w szczególnosci pochodne cis-stilbenu, pochodne 4,5-difenylo-1,3-oksazolu, pochodne 1-metylo-4,5-difenylo-1H-imidazolu, a takze farmaceutycznie dopuszczalne sole powyzszych substancji. Nowe pochodne, z uwagi na potencjalna aktywnosc antymitotyczna, zwiazana z hamowaniem polimeryzacji tubuliny oraz aktywnosc antyangiogenna, moga znalezc zastosowanie jako skladniki preparatów wykorzystywanych w leczeniu nowotworów.
PL398659A 2012-03-29 2012-03-29 Nowe pochodne (Z)-1,2-difenyloetenu PL220039B1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL398659A PL220039B1 (pl) 2012-03-29 2012-03-29 Nowe pochodne (Z)-1,2-difenyloetenu
PCT/PL2013/000042 WO2013147629A1 (en) 2012-03-29 2013-03-28 The new derivatives of (z)-1,2-diphenylethene
US14/389,281 US10065935B2 (en) 2012-03-29 2013-03-28 Derivatives of (Z)-1,2-diphenylethene
EP13723574.3A EP2885280A1 (en) 2012-03-29 2013-03-28 The new derivatives of (z)-1,2-diphenylethene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL398659A PL220039B1 (pl) 2012-03-29 2012-03-29 Nowe pochodne (Z)-1,2-difenyloetenu

Publications (2)

Publication Number Publication Date
PL398659A1 true PL398659A1 (pl) 2013-09-30
PL220039B1 PL220039B1 (pl) 2015-08-31

Family

ID=48464059

Family Applications (1)

Application Number Title Priority Date Filing Date
PL398659A PL220039B1 (pl) 2012-03-29 2012-03-29 Nowe pochodne (Z)-1,2-difenyloetenu

Country Status (4)

Country Link
US (1) US10065935B2 (pl)
EP (1) EP2885280A1 (pl)
PL (1) PL220039B1 (pl)
WO (1) WO2013147629A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103819483B (zh) * 2014-02-18 2016-04-13 中国人民解放军第四军医大学 防治肺动脉高压的药物及其合成和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2432640A1 (en) * 2000-12-21 2002-06-27 Cancer Research Technology Limited Substituted stilbenes, their reactions and anticancer activity
ITRM20030355A1 (it) 2003-07-18 2005-01-19 Sigma Tau Ind Farmaceuti Composti ad attivita' citotossica derivati della combretastatina.

Also Published As

Publication number Publication date
US20150065727A1 (en) 2015-03-05
PL220039B1 (pl) 2015-08-31
WO2013147629A1 (en) 2013-10-03
US10065935B2 (en) 2018-09-04
EP2885280A1 (en) 2015-06-24

Similar Documents

Publication Publication Date Title
NI201700020A (es) Compuestos de aminopirimidinilo como inhibidores de jak
JOP20180104B1 (ar) مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
CL2017000240A1 (es) Compuestos activos hacia bromodominios
CL2017000469A1 (es) Derivados de tetrahidronaftaleno que inhiben la proteina mcl-1
CR20150639A (es) Derivados de benzimidazol como inhbidores de bromodominio
MX2016001480A (es) Formulacion de inhibidores de syk.
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
CL2012003415A1 (es) Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer .
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
CR20150326A (es) Inhibidores de autotaxina
MX2017004471A (es) Compuestos de triazolopiridina y métodos para el tratamiento de fibrosis cística.
CL2016001889A1 (es) (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1.
CO7160104A2 (es) Inhibidores de virus de hepatitis c
CR20160564A (es) Dinucleótidos cíclicos como moduladores de sting
BR112016008468A2 (pt) Composto de fórmula, composição farmacêutica, composto, uso de um composto e método para o tratamento ou melhora de câncer
CL2014002873A1 (es) Compuestos derivados de pirimidin-amina o triazin-amina, inhibidores de adn-pk; composicion farmaceutica; y su uso para el tratamiento del cancer.
CL2014001793A1 (es) Compuestos derivados de 1,3,5-triazinas sustituidas y sus sales, como inhibidores de la idh2 mutante; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer.
CL2014000887A1 (es) Compuestos derivados de 1-fenil-imidazol condensado y sus sales, inhibidores de proteinas quinasas; composicion farmaceutica que los comprende; y su uso para el tratamiento de una condicion donde se desea la inhibicion de la quinasa del fgfr tal como cancer.
MX2015015409A (es) Proceso para la preparacion de eritrocitos cargados con una o mas sustancias de interes farmaceutico y eritrocitos asi obtenidos.
CL2014001865A1 (es) Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer.
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
CR20170076A (es) Derivados de pirimidima sustituidos con heterociclilo opcionalmente condensados útiles para el tratamiento de enfermedades inflamatorias, metabólicas, oncológicas y autoinmunitarias
BR112014028042A2 (pt) inibidores de nampt
MX2016015434A (es) Combinaciones farmaceuticas para tratar cancer.
EA201490688A1 (ru) 2-тиопиримидиноны